Factors intrinsic and extrinsic to blood hamper the development of a routine blood test for human prion diseases

Journal of General Virology

Volumn 96, Issue 3, 2015, Pages 479-493

  Abdel Haq, Hanin ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; LECTIN; LIGAND; PLASMINOGEN; POLYMER; PRION PROTEIN; PROTEIN; PRION;

BIOASSAY; BLOOD ANALYSIS; BLOOD COMPONENT; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CLINICAL EVALUATION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOASSAY; IMMUNOCAPILLARY ELECTROPHORESIS; IMMUNODETECTION; IMMUNOPRECIPITATION; LECTIN BINDING; MASS SPECTROMETRY; MULTIMER DETECTION SYSTEM; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONFORMATION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEOMICS; REAL TIME QUAKING INDUCED CONVERSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; RISK FACTOR; SCIENTIST; SENSITIVITY AND SPECIFICITY; SOLID STATE; SOLID STATE BINDING MATRIX; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURFACE FLUORESCENCE INTENSITY DISTRIBUTION ANALYSIS; SURROUNDING OPTICAL FIBRE IMMUNOASSAY; VIRUS DETECTION; WESTERN BLOTTING; BLOOD; PRION DISEASES; PROCEDURES; SEROLOGY;

ANIMALIA;

HUMANS; PRION DISEASES; PRIONS; SEROLOGIC TESTS;

EID: 84923700279     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.070979-0     Document Type: Review

References (92)

1. Abdel-Haq, H. (2012). Recent developments in cell biology: role of glycosylation in prion diseases. In Prions and Prion Diseases: New Developments, pp. 85-114. Edited by J.-M. Verdier. New York: Nova Science. https://www.novapublishers.com/catalog/product_info.php?products_id=43852.
2. Abdel-Haq, H., Lu, M., Cardone, F., Liu, Q. G., Puopolo, M. & Pocchiari, M. (2009). Efficacy of phthalocyanine tetrasulfonate against mouse-adapted human prion strains. Arch Virol 154, 1005-1007.
3. Amorfix Life Sciences Press Release (2008). Amorfix vCJD assay achieves 100% sensitivity and 100% specificity on 1,000 fresh samples from UK blood donors. http://www.amorfix.com/pdf_press/pr_2008/2008_10_17_AMF_vCJD_NIBSC_Fresh_Results.pdf.
4. An, S. S. A., Lim, K. T., Oh, H. J., Lee, B. S., Zukic, E., Ju, Y. R., Yokoyama, T., Kim, S. Y. & Welker, E. (2010). Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System. Biochem Biophys Res Commun 392, 505-509.
5. Atarashi, R., Wilham, J. M., Christensen, L., Hughson, A. G., Moore, R. A., Johnson, L. M., Onwubiko, H. A., Priola, S. A. & Caughey, B. (2008). Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5, 211-212.
6. Atarashi, R., Satoh, K., Sano, K., Fuse, T., Yamaguchi, N., Ishibashi, D., Matsubara, T., Nakagaki, T., Yamanaka, H. & other authors (2011). Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17, 175-178.
7. Bannach, O., Birkmann, E., Reinartz, E., Jaeger, K. E., Langeveld, J. P., Rohwer, R. G., Gregori, L., Terry, L. A., Willbold, D. & Riesner, D. (2012). Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS ONE 7, e36620.
8. Bannach, O., Reinartz, E., Henke, F., Dreßen, F., Oelschlegel, A., Kaatz, M., Groschup, M. H., Willbold, D., Riesner, D. & Birkmann, E. (2013). Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases. Vet Microbiol 166, 102-108.
9. Batxelli-Molina, I., Salvetat, N., Andréoletti, O., Guerrier, L., Vicat, G., Molina, F. & Mourton-Gilles, C. (2010). Ovine serum biomarkers of early and late phase scrapie. BMC Vet Res 6, 49.
10. Bessen, R. A. & Marsh, R. F. (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68, 7859-7868.
11. Biasini, E., Seegulam, M. E., Patti, B. N., Solforosi, L., Medrano, A. Z., Christensen, H. M., Senatore, A., Chiesa, R., Williamson, R. A. & Harris, D. A. (2008). Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies. J Neurochem 105, 2190-2204.
12. Biasini, E., Tapella, L., Mantovani, S., Stravalaci, M., Gobbi, M., Harris, D. A. & Chiesa, R. (2009). Immunopurification of pathological prion protein aggregates. PLoS ONE 4, e7816.
13. Bolton, D. C., McKinley, M. P. & Prusiner, S. B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
14. Brown, P. (2001b). Creutzfeldt-Jakob disease: blood infectivity and screening tests. Semin Hematol 38 (Suppl 9), 2-6.
15. Brown, P., Rohwer, R. G., Dunstan, B. C., MacAuley, C., Gajdusek, D. C. & Drohan, W. N. (1998). The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38, 810-816.
16. Brown, P., Cervenáková, L. & Diringer, H. (2001a). Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 137, 5-13.
17. Castilla, J., Saá, P. & Soto, C. (2005). Detection of prions in blood. Nat Med 11, 982-985.
18. Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F. & Caughey, W. S. (1991). Secondary structure analysis of the scrapieassociated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
19. Cervenakova, L., Yakovleva, O., McKenzie, C., Kolchinsky, S., McShane, L., Drohan, W. N. & Brown, P. (2003). Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43, 1687-1694.
20. Chang, B., Cheng, X., Yin, S., Pan, T., Zhang, H., Wong, P., Kang, S. C., Xiao, F., Yan, H. & other authors (2007). Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol 14, 36-43.
21. Choe, L. H., Green, A., Knight, R. S., Thompson, E. J. & Lee, K.H. (2002). Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease. Electrophoresis 23, 2242-2246.
22. Chohan, G., Llewelyn, C., Mackenzie, J., Cousens, S., Kennedy, A., Will, R. & Hewitt, P. (2010). Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 50, 1003-1006.
23. Chung, E., Prelli, F., Dealler, S., Lee, W. S., Chang, Y. T. & Wisniewski, T. (2011). Styryl-based and tricyclic compounds as potential antiprion agents. PLoS ONE 6, e24844.
24. Collinge, J., Whitfield, J., McKintosh, E., Beck, J., Mead, S., Thomas, D. J. & Alpers, M. P. (2006). Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367, 2068-2074.
25. Debray, H., Decout, D., Strecker, G., Spik, G. & Montreuil, J. (1981). Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem 117, 41-55.
26. Diedrich, J. F., Minnigan, H., Carp, R. I., Whitaker, J. N., Race, R., Frey, W., II & Haase, A. T. (1991). Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65, 4759-4768.
27. Doh-ura, K., Ishikawa, K., Murakami-Kubo, I., Sasaki, K., Mohri, S., Race, R. & Iwaki, T. (2004). Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78, 4999-5006.
28. Edgeworth, J. A., Farmer, M., Sicilia, A., Tavares, P., Beck, J., Campbell, T., Lowe, J., Mead, S., Rudge, P. & other authors (2011). Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377, 487-493.
29. Edwards, J. C., Moore, S. J., Hawthorn, J. A., Neale, M. H. & Terry, L. A. (2010). PrP(Sc) is associated with B cells in the blood of scrapieinfected sheep. Virology 405, 110-119.
30. Elder, A. M., Henderson, D. M., Nalls, A. V., Wilham, J. M., Caughey, B. W., Hoover, E. A., Kincaid, A. E., Bartz, J. C. & Mathiason, C. K. (2013). In vitro detection of prionemia in TSE-infected cervids and hamsters. PLoS ONE 8, e80203.
31. Ernoult, E., Bourreau, A., Gamelin, E. & Guette, C. (2010). A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol 2010, 927917.
32. European Commission DG Health and Consumer Directorate (2012). Guideline for the CE marking of blood based in vitro diagnostic medical devices for vCJD based on detection of abnormal PrP. http://ec.europa.eu/health/medical-devices/files/meddev/2_14_ 4_ol_en.pdf.
33. Forloni, G., Iussich, S., Awan, T., Colombo, L., Angeretti, N., Girola, L., Bertani, I., Poli, G., Caramelli, M. & other authors (2002). Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 99, 10849-10854.
34. Gabizon, R. M., McKinley, M. P. & Prusiner, S. B. (1987). Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A 84, 4017-4021.
35. Gasset, M., Baldwin, M. A., Fletterick, R. J. & Prusiner, S. B. (1993). Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A 90, 1-5.
36. Gregori, L., McCombie, N., Palmer, D., Birch, P., Sowemimo-Coker, S. O., Giulivi, A. & Rohwer, R. G. (2004). Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364, 529-531.
37. Guillaume, E., Zimmermann, C., Burkhard, P. R., Hochstrasser, D. F. & Sanchez, J. C. (2003). A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 3, 1495-1499.
38. Guntz, P., Walter, C., Schosseler, P., Morel, P., Coste, J. & Cazenave, J.-P. (2010). Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20 000 samples. Transfusion 50, 989-995.
39. Herzog, C., Salès, N., Etchegaray, N., Charbonnier, A., Freire, S., Dormont, D., Deslys, J. P. & Lasmézas, C. I. (2004). Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363, 422-428.
40. Hewitt, P. E., Llewelyn, C. A., Mackenzie, J. & Will, R. G. (2006). Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91, 221-230.
41. Holada, K., Vostal, J. G., Theisen, P. W., MacAuley, C., Gregori, L. & Rohwer, R. G. (2002). Scrapie infectivity in hamster blood is not associated with platelets. J Virol 76, 4649-4650.
42. Honda, H., Sasaki, K., Minaki, H., Masui, K., Suzuki, S. O., Doh-Ura, K. & Iwaki, T. (2012). Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion. Neuropathology 32, 124-132.
43. Houston, F., Foster, J. D., Chong, A., Hunter, N. & Bostock, C. J. (2000). Transmission of BSE by blood transfusion in sheep. Lancet 356, 999-1000.
44. Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. & Houston, F. (2002). Transmission of prion diseases by blood transfusion. J Gen Virol 83, 2897-2905.
45. Jackson, G. S., Burk-Rafel, J., Edgeworth, J. A., Sicilia, A., Abdilahi, S., Korteweg, J., Mackey, J., Thomas, C., Wang, G. & other authors (2014). Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 71, 421-428.
46. Kocisko, D. A., Lansbury, P. T., Jr & Caughey, B. (1996). Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35, 13434-13442.
47. Kocisko, D. A., Caughey, B., Morrey, J. D. & Race, R. E. (2006a). Enhanced antiscrapie effect using combination drug treatment. Antimicrob Agents Chemother 50, 3447-3449.
48. Kocisko, D. A., Vaillant, A., Lee, K. S., Arnold, K. M., Bertholet, N., Race, R. E., Olsen, E. A., Juteau, J. M. & Caughey, B. (2006b). Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother 50, 1034-1044.
49. Korth, C., Stierli, B., Streit, P., Moser, M., Schaller, O., Fischer, R., Schulz-Schaeffer, W., Kretzschmar, H., Raeber, A. & other authors (1997). Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390, 74-77.
50. Lacroux, C., Vilette, D., Fernández-Borges, N., Litaise, C., Lugan, S., Morel, N., Corbière, F., Simon, S., Simmons, H. & other authors (2012). Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 86, 2056-2066.
51. Lacroux, C., Comoy, E., Moudjou, M., Perret-Liaudet, A., Lugan, S., Litaise, C., Simmons, H., Jas-Duval, C., Lantier, I. & other authors (2014). Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog 10, e1004202.
52. Lourenco, P. C., Schmerr, M. J., MacGregor, I., Will, R. G., Ironside, J. W. & Head, M. W. (2006). Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease. J Gen Virol 87, 3119-3124.
53. Lukan, A., Vranac, T. & Curin Šerbec, V. (2013). TSE diagnostics: recent advances in immunoassaying prions. Clin Dev Immunol 2013, 360604.
54. Madera, M., Mechref, Y., Klouckova, I. & Novotny, M. V. (2007). Highsensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/ tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 845, 121-137.
55. Masters, C. L. & Richardson, E. P., Jr (1978). Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101, 333-344.
56. Minor, P. D. (2004). Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion. Vox Sang 86, 164-170.
57. Murayama, Y., Yoshioka, M., Okada, H., Takata, M., Yokoyama, T. & Mohri, S. (2007). Urinary excretion and blood level of prions in scrapie-infected hamsters. J Gen Virol 88, 2890-2898.
58. Murman, D. L. (2012). Early treatment of Parkinson’s disease: opportunities for managed care. Am J Manag Care 18 (Suppl), S183-S188.
59. Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B. & other authors (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
60. Orrú, C. D., Wilham, J. M., Hughson, A. G., Raymond, L. D., McNally, K. L., Bossers, A., Ligios, C. & Caughey, B. (2009). Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 22, 515-521.
61. Orrú, C. D., Wilham, J. M., Raymond, L. D., Kuhn, F., Schroeder, B., Raeber, A. J. & Caughey, B. (2011). Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2, e00078-11.
62. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J. & Cohen, F. E. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90, 10962-10966.
63. Pan, T., Li, R., Wong, B. S., Kang, S. C., Ironside, J. & Sy, M. S. (2005a). Novel antibody-lectin enzyme-linked immunosorbent assay that distinguishes prion proteins in sporadic and variant cases of Creutzfeldt-Jakob disease. J Clin Microbiol 43, 1118-1126.
64. Pan, T., Chang, B., Wong, P., Li, C., Li, R., Kang, S. C., Robinson, J. D., Thompsett, A. R., Tein, P. & other authors (2005b). An aggregationspecific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates. J Virol 79, 12355-12364.
65. Pan, T., Sethi, J., Nelsen, C., Rudolph, A., Cervenakova, L., Brown, P. & Orser, C. S. (2007). Detection of misfolded prion protein in blood with conformationally sensitive peptides. Transfusion 47, 1418-1425.
66. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
67. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-13383.
68. Relaño-Ginés, A., Lehmann, S., Bencsik, A., Herva, M. E., Torres, J. M. & Crozet, C. A. (2011). Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. J Infect Dis 204, 1038-1045.
69. Rubenstein, R., Chang, B., Gray, P., Piltch, M., Bulgin, M. S., Sorensen-Melson, S. & Miller, M. W. (2010). A novel method for preclinical detection of PrPSc in blood. J Gen Virol 91, 1883-1892.
70. Rudd, P. M., Endo, T., Colominas, C., Groth, D., Wheeler, S. F., Harvey, D. J., Wormald, M. R., Serban, H., Prusiner, S. B. & other authors (1999). Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 96, 13044-13049.
71. Ryou, C., Titlow, W. B., Mays, C. E., Bae, Y. & Kim, S. (2011). The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 32, 3141-3149.
72. Saá, P., Castilla, J. & Soto, C. (2006). Presymptomatic detection of prions in blood. Science 313, 92-94.
73. Saborio, G. P., Permanne, B. & Soto, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813.
74. Sáez-Valero, J., Fodero, L. R., Sjögren, M., Andreasen, N., Amici, S., Gallai, V., Vanderstichele, H., Vanmechelen, E., Parnetti, L. & other authors (2003). Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer’s disease. J Neurosci Res 72, 520-526.
75. Segarra, C., Bougard, D., Moudjou, M., Laude, H., Béringue, V. & Coste, J. (2013). Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS ONE 8, e69632.
76. Sheinerman, K. S. & Umansky, S. R. (2013). Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7, 150.
77. Silveyra, M. X., Cuadrado-Corrales, N., Marcos, A., Barquero, M. S., Rábano, A., Calero, M. & Sáez-Valero, J. (2006). Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease. J Neurochem 96, 97-104.
78. Sim, V. L. (2012). Prion disease: chemotherapeutic strategies. Infect Disord Drug Targets 12, 144-160.
79. Soto, C. (2004). Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2, 809-819.
80. Talens, S., Leebeek, F. W., Demmers, J. A. & Rijken, D. C. (2012). Identification of fibrin clot-bound plasma proteins. PLoS ONE 7, e41966.
81. Tattum, M. H., Jones, S., Pal, S., Collinge, J. & Jackson, G. S. (2010a). Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 50, 996-1002.
82. Tattum, M. H., Jones, S., Pal, S., Khalili-Shirazi, A., Collinge, J. & Jackson, G. S. (2010b). A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion 50, 2619-2627.
83. Terry, L. A., Howells, L., Hawthorn, J., Edwards, J. C., Moore, S. J., Bellworthy, S. J., Simmons, H., Lizano, S., Estey, L. & other authors (2009). Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents. J Virol 83, 12552-12558.
84. Thackray, A. M., Klein, M. A. & Bujdoso, R. (2003). Subclinical prion disease induced by oral inoculation. J Virol 77, 7991-7998.
85. Thorne, L. & Terry, L. A. (2008). In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89, 3177-3184.
86. Triantaphyllidou, I. E., Sklaviadis, T. & Vynios, D. H. (2006). Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates. Anal Biochem 359, 176-182.
87. Trieschmann, L., Navarrete Santos, A., Kaschig, K., Torkler, S., Maas, E., Schätzl, H. & Böhm, G. (2005). Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol 5, 26.
88. Tsukui, K., Takata, M. & Tadokoro, K. (2007). A potential blood test for transmissible spongiform encephalopathies by detecting carbohydrate- dependent aggregates of PrPres-like proteins in scrapieinfected hamster plasma. Microbiol Immunol 51, 1221-1231.
89. UK Health Protection Agency (2007). Fourth case of transfusionassociated variant-CJD infection. http://www.hpa.org.uk/hpr/archives/ 2007/news2007/news0307.htm#cjd [accessed Dec 24, 2010].
90. Völkel, D., Zimmermann, K., Zerr, I., Bodemer, M., Lindner, T., Turecek, P. L., Poser, S. & Schwarz, H. P. (2001). Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 41, 441-448.
91. Wei, X., Herbst, A., Ma, D., Aiken, J. & Li, L. (2011). A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome. J Proteome Res 10, 2687-2702.
92. Yakovleva, O., Janiak, A., McKenzie, C., McShane, L., Brown, P. & Cervenakova, L. (2004). Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 44, 1700-1705.